Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
6.76
-0.02 (-0.30%)
Jun 17, 2025, 4:00 PM - Market closed
Neuphoria Therapeutics Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2015 - 2019 |
| Operating Revenue | 15.66 | - | - | 0.18 | - | 0.03 | Upgrade
|
| Other Revenue | - | - | - | 3.99 | 0.7 | 2.03 | Upgrade
|
| Revenue | 15.66 | - | - | 4.17 | 0.7 | 2.07 | Upgrade
|
| Revenue Growth (YoY) | - | - | - | 499.60% | -66.32% | -59.99% | Upgrade
|
| Cost of Revenue | -1.07 | - | - | 11.02 | 4.32 | 4.02 | Upgrade
|
| Gross Profit | 16.73 | - | - | -6.85 | -3.62 | -1.96 | Upgrade
|
| Selling, General & Admin | 8.08 | 8.47 | 8.91 | 5.28 | 4.23 | 3.35 | Upgrade
|
| Research & Development | 9.12 | 9.32 | 12.65 | - | - | - | Upgrade
|
| Other Operating Expenses | - | - | - | -0 | -0.15 | -0.14 | Upgrade
|
| Operating Expenses | 17.2 | 17.8 | 21.56 | 5.27 | 4.08 | 3.21 | Upgrade
|
| Operating Income | -0.47 | -17.8 | -21.56 | -12.12 | -7.7 | -5.17 | Upgrade
|
| Interest Expense | - | - | - | -0.02 | -1.07 | -1.26 | Upgrade
|
| Interest & Investment Income | 0.11 | 0.22 | 0.32 | 0.01 | 0 | 0.04 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.46 | -0.21 | 0.31 | 0.25 | 0.81 | -0.43 | Upgrade
|
| Other Non Operating Income (Expenses) | 3.29 | - | - | -2.59 | -1.22 | -1.01 | Upgrade
|
| EBT Excluding Unusual Items | 3.38 | -17.79 | -20.93 | -14.48 | -9.18 | -7.82 | Upgrade
|
| Gain (Loss) on Sale of Investments | 2.21 | 2.21 | -0.59 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | -0 | -0.02 | 0.12 | Upgrade
|
| Other Unusual Items | - | - | - | -0.65 | 2.54 | 3.54 | Upgrade
|
| Pretax Income | 5.59 | -15.58 | -21.52 | -15.12 | -6.66 | -4.16 | Upgrade
|
| Income Tax Expense | -0.24 | -0.09 | -0.14 | -0.13 | -0.14 | -0.14 | Upgrade
|
| Earnings From Continuing Operations | 5.83 | -15.49 | -21.38 | -14.99 | -6.52 | -4.02 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | - | - | -0.9 | Upgrade
|
| Net Income | 5.83 | -15.49 | -21.38 | -14.99 | -6.52 | -4.91 | Upgrade
|
| Net Income to Common | 5.83 | -15.49 | -21.38 | -14.99 | -6.52 | -4.91 | Upgrade
|
| Shares Outstanding (Basic) | 1,798 | 1,798 | 1,469 | 1,353 | 780 | 545 | Upgrade
|
| Shares Outstanding (Diluted) | 1,798 | 1,798 | 1,469 | 1,353 | 780 | 545 | Upgrade
|
| Shares Change (YoY) | 352.55% | 22.39% | 8.53% | 73.52% | 43.14% | 4.52% | Upgrade
|
| EPS (Basic) | 0.00 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | Upgrade
|
| EPS (Diluted) | 0.00 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | Upgrade
|
| Free Cash Flow | 0.65 | -14.68 | -14.64 | -14.99 | -5.65 | -2.7 | Upgrade
|
| Free Cash Flow Per Share | - | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | Upgrade
|
| Gross Margin | 106.82% | - | - | -164.21% | - | -94.76% | Upgrade
|
| Operating Margin | -3.00% | - | - | -290.62% | -1107.29% | -250.19% | Upgrade
|
| Profit Margin | 37.20% | - | - | -359.34% | -937.11% | -237.89% | Upgrade
|
| Free Cash Flow Margin | 4.16% | - | - | -359.30% | -812.46% | -130.70% | Upgrade
|
| EBITDA | -0.02 | -17.35 | -21.23 | -11.49 | -7 | -4.19 | Upgrade
|
| EBITDA Margin | -0.16% | - | - | -275.36% | - | -202.73% | Upgrade
|
| D&A For EBITDA | 0.45 | 0.45 | 0.33 | 0.64 | 0.7 | 0.98 | Upgrade
|
| EBIT | -0.47 | -17.8 | -21.56 | -12.12 | -7.7 | -5.17 | Upgrade
|
| EBIT Margin | -3.00% | - | - | -290.62% | - | -250.19% | Upgrade
|
Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.